Clinical trial
A Phase Ia Dose Escalation, Randomized, Double-Blinded, and Placebo- Controlled Clinical Study of Single Dose and Multiple Doses of XW001 Inhalation Solution in Healthy Adult Subjects
NCT05642403 is registered in ClinicalTrials.gov with Hangzhou Sciwind Biosciences Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase Ia Dose Escalation, Randomized, Double-Blinded, and Placebo- Controlled Clinical Study of Single Dose and Multiple Doses of XW001 Inhalation Solution in Healthy Adult Subjects
- Lead sponsor
- Hangzhou Sciwind Biosciences Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 3, 2021
- Completion date
- June 20, 2022
- Enrollment
- 81 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.